Consolidated Statements of Changes in Temporary Equity and Stockholders' Equity - USD ($) $ in Millions	Total	Series A Senior Preferred Shares	Redeemable non- controlling interest	Preferred Dividends on Series A Senior Preferred Shares	Common stock	Additional paid-In capital	Retained earnings	Retained earnings Series A Senior Preferred Shares	Retained earnings Preferred Dividends on Series A Senior Preferred Shares	Accumulated other comprehensive loss	Non- controlling interest
Temporary equity, ending balance (in shares) at Dec. 31, 2022		0
Ending balance at Dec. 31, 2022		$ 0.0	$ 0.0
Balance (in shares) at Dec. 31, 2021					110,618,049
Balance at Dec. 31, 2021	$ 1,071.1				$ 227.5	$ 59.5	$ 839.6			$ (56.0)	$ 0.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	319.7						319.7
Other comprehensive (loss) income	(29.1)									(29.1)
Stock option exercises (in shares)					159,920
Stock option exercises	5.8				$ 7.2	(1.4)
Issuance of common stock related to vesting of share units (in shares)					103,394
Issuance of common stock related to vesting of share units	(3.8)				$ 3.0	(6.8)
Share-based continuing employment costs related to business combinations	7.5				$ 8.6	(1.1)
Share-based payments expense	34.2					34.2
Equity-classified share units dividend equivalents	0.0					0.9	(0.9)
Dividends paid to common stockholders	(115.2)
Balance (in shares) at Dec. 31, 2022					110,881,363
Balance at Dec. 31, 2022	$ 1,290.1				$ 246.3	85.3	1,043.2			(85.1)	0.5
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)			(0.5)
NCI acquired in business combination			8.9
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs (in shares)		485,000,000
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs		$ 482.0
Temporary equity, ending balance (in shares) at Dec. 31, 2023	485,000,000	485,000,000
Ending balance at Dec. 31, 2023		$ 482.0	8.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 206.5						206.5
Other comprehensive (loss) income	41.1									41.1
Stock option exercises (in shares)					723,443
Stock option exercises	34.5				$ 42.9	(8.4)
Issuance of common stock related to vesting of share units (in shares)					467,747
Issuance of common stock related to vesting of share units	(19.0)				$ 17.4	(36.4)
Issuance of common stock related to ESPP purchase (in shares)					180,503
Issuance of common stock related to ESPP	9.2				$ 11.4	(2.2)
Issuance of common stock related to business combination (in shares)					70,339,723
Issuance of common stock related to business combination	3,712.9				$ 3,712.9
Share-based continuing employment costs related to business combinations	3.0				$ 8.3	(5.3)
Replacement of share-based awards in business combination	13.1					13.1
Share-based payments expense	40.3					40.3
Equity-classified share units dividend equivalents	0.0					1.6	(1.6)
NCI acquired in business combination	1.8										1.8
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs (in shares)					251,163
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs	15.0				$ 15.0
Participating dividends on Series A Senior Preferred Shares		$ (7.3)		$ (24.3)				$ (7.3)	$ (24.3)
Dividends paid to common stockholders	$ (298.0)
Balance (in shares) at Dec. 31, 2023	182,843,942				182,843,942
Balance at Dec. 31, 2023	$ 5,019.0				$ 4,054.2	88.0	918.5			(44.0)	2.3
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)			(0.3)
Temporary equity, ending balance (in shares) at Dec. 31, 2024	485,000,000	485,000,000
Ending balance at Dec. 31, 2024		$ 482.0	$ 8.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 413.1						413.1
Other comprehensive (loss) income	(80.8)									(80.8)
Stock option exercises (in shares)					1,044,547
Stock option exercises	49.3				$ 61.4	(12.1)
Issuance of common stock related to vesting of share units (in shares)					335,372
Issuance of common stock related to vesting of share units	(15.7)				$ 14.3	(30.0)
Issuance of common stock related to ESPP purchase (in shares)					513,142
Issuance of common stock related to ESPP	26.2				$ 32.9	(6.7)
Share-based continuing employment costs related to business combinations (in shares)					(4,421)
Share-based continuing employment costs related to business combinations	(0.1)				$ 0.3	(0.4)
Share-based payments expense	55.5					55.5
Equity-classified share units dividend equivalents	0.0					1.1	(1.1)
Participating dividends on Series A Senior Preferred Shares		$ (7.5)		$ (26.7)				$ (7.5)	$ (26.7)
Dividends paid to common stockholders	$ (206.0)
Balance (in shares) at Dec. 31, 2024	184,732,582				184,732,582
Balance at Dec. 31, 2024	$ 5,226.3				$ 4,163.1	$ 95.4	$ 1,090.3			$ (124.8)	$ 2.3